SGD Pharma has been recognized at the CDP Awards Europe for its climate leadership, following its inclusion in the 2025 CDP A List.

This recognition highlights the company's commitment to measurable environmental performance, robust climate governance and the integration of climate considerations into strategic and industrial decision-making.

The recognition was received by Olivier Rousseau, CEO of SGD Pharma, alongside members of the ESG team.

CDP Awards Europe: Recognizing Climate Leadership

The CDP Awards Europe brought together leading sustainability and business representatives to recognize organizations placing environmental responsibility at the heart of their strategies.

The event highlighted companies demonstrating that climate leadership requires more than ambitious commitments. It also depends on measurable results, transparent reporting and effective governance.

During the event, CDP also presented insights from its Corporate Health Check Europe, an assessment of companies' progress on environmental commitments.

For SGD Pharma, the recognition reflects the importance of translating climate ambitions into concrete industrial and organizational action.

SGD Pharma Joins the 2025 CDP A List

SGD Pharma's recognition follows its strong performance in the 2025 CDP assessment.

The company achieved the following scores:

  • Climate Change: A — CDP A List
  • Water Security: B

Achieving an A rating for Climate Change recognizes SGD Pharma's approach to climate governance, environmental risk management and emissions reduction.

These results demonstrate the importance of integrating environmental considerations into business strategy and industrial operations.

Climate Governance at the Heart of Business Strategy

Commenting on the recognition, Olivier Rousseau, CEO of SGD Pharma, highlighted the company's operational approach to climate governance.

He emphasized the integration of climate-related risks and opportunities into corporate and industrial decision-making, supported by a credible and closely monitored emissions-reduction trajectory.

For SGD Pharma, climate is not a peripheral consideration. It is a strategic driver of resilience and long-term business performance.

The company remains committed to translating its climate leadership into measurable, science-based action.

Turning Climate Commitments into Measurable Progress

The CDP recognition reinforces SGD Pharma's commitment to combining environmental ambition with operational performance.

Through climate governance, emissions monitoring and science-based action, the company continues to integrate sustainability into its long-term industrial strategy.

Being part of the CDP A List is an important milestone — and a motivation to keep turning climate commitments into measurable results.